Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR52 | Q9Y2T5 | 16/20 | 0.57 |
| ▸ | RORC | P51449 | 1/20 | 0.40 |
| ▸ | CMA1 | P23946 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23803849 | 1.00 | GPR52 (0.57) | GPR52RORCCMA1 | |
| SCHEMBL23803837 | 0.91 | GPR52 (0.56) | GPR52 | |
| SCHEMBL30152179 | 0.91 | GPR52 (0.56) | GPR52 | |
| SCHEMBL30120850 | 0.91 | GPR52 (0.56) | GPR52 | |
| SCHEMBL23803890 | 0.91 | GPR52 (0.56) | GPR52 | |
| SCHEMBL23803883 | 0.90 | GPR52 (0.55) | GPR52 | |
| SCHEMBL30120903 | 0.90 | GPR52 (0.55) | GPR52 | |
| SCHEMBL23803789 | 0.90 | GPR52 (0.55) | GPR52 | |
| SCHEMBL30120942 | 0.90 | GPR52 (0.55) | GPR52 | |
| SCHEMBL23803891 | 0.89 | GPR52 (0.54) | GPR52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115515681-B | GPR52 modulator compounds | 奈克斯拉制药英国有限公司 | 2024-09-03 | — | — | CN | disclosed |
| US-20240254101-A1 | GPR52 MODULATOR COMPOUNDS | HEPTARES THERAPEUTICS LIMITED (GB) | 2024-08-01 | — | — | US | disclosed |
| EP-4117784-A1 | GPR52 MODULATOR COMPOUNDS | Heptares Therapeutics Limited (GB) | 2023-01-18 | — | — | EP | disclosed |
| CN-115515681-A | GPR52 modulator compounds | 赫普泰雅治疗有限公司 | 2022-12-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240254101-A1 | GPR52 MODULATOR COMPOUNDS | GPR52, GPR119, GPR4 | GPR52 1/4885RORC 384/4885CMA1 3788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.